Ausgabe 3/2012
Inhalt (15 Artikel)
Recent Advances in the Genetics of Cerebellar Ataxias
Anna Sailer, Henry Houlden
Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
Blake Byers, Hsiao-lu Lee, Renee Reijo Pera
Recent Advances in the Genetics of the ALS-FTLD Complex
Huw R. Morris, Adrian J. Waite, Nigel M. Williams, James W. Neal, Derek J. Blake
Mechanisms of LRRK2-Mediated Neurodegeneration
Elpida Tsika, Darren J. Moore
Schizophrenia Genetics: Putting All the Pieces Together
Simon L. Girard, Patrick A. Dion, Guy A. Rouleau
Chemotherapy-Related Cognitive Dysfunction
Jeffrey S. Wefel, Sanne B. Schagen
Radiation Necrosis: Relevance with Respect to Treatment of Primary and Secondary Brain Tumors
James Fink, Donald Born, Marc C. Chamberlain
Temozolomide Dosing Regimens for Glioma Patients
Herwig M. Strik, Christine Marosi, Bernd Kaina, Bart Neyns
Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis
David Neal Franz, Brian D. Weiss
Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma
Ghazaleh Tabatabai, Monika Hegi, Roger Stupp, Michael Weller
Disorders of the Optic Nerve in Mitochondrial Cytopathies: New Ideas on Pathogenesis and Therapeutic Targets
Kamil S. Sitarz, Patrick F. Chinnery, Patrick Yu-Wai-Man
Thyroid Eye Disease: Towards an Evidence Base for Treatment in the 21st Century
Erin F. Gillespie, Terry J. Smith, Raymond S. Douglas
What We Know about the Generation of Nystagmus and Other Ocular Oscillations: Are We Closer to Identifying Therapeutic Targets?
Rebecca Jane McLean, Irene Gottlob, Frank Antony Proudlock
Papilledema: Are We Any Nearer to a Consensus on Pathogenesis and Treatment?
Andrew G. Lee, Michael Wall